N.A. Skripkina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
N.A. Skripkina has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- A.D. Chebotareva
Russian Medical Academy of Continuous Professional Education
1 shared publication - Irina G. Smolentseva
Russian Medical Academy of Continuous Professional Education
1 shared publication - Karim R. Yanin
Botkin Hospital
1 shared publication - Oleg S. Levin
Russian Medical Academy of Continuous Professional Education
1 shared publication
Latest Publications
- 3 November 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Neurodegeneration with brain iron accumulation type 4
Neurodegeneration with brain iron accumulation (NBIA) is a heterogeneous group of hereditary disorders characterized by iron accumulation in the brain, predominantly affecting the basal ganglia. These conditions present with multisystem clinical manifestations, most notably motor, cognitive, and behavioral disorders. To date, ten variants of NBIA have been identified, with BPAN, PKAN, and PLAN being the most common. This report presents five confirmed cases of type 4 NBIA, termed mitochondrial membrane protein-associated neurodegeneration (MPAN), detailing clinical and neuroimaging findings and its molecular genetic characteristics; MPAN is associated with mutations in the C19orf12 gene encoding a mitochondrial membrane protein.
- 3 November 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Neurodegeneration with brain iron accumulation type 4
Neurodegeneration with brain iron accumulation (NBIA) is a heterogeneous group of hereditary disorders characterized by iron accumulation in the brain, predominantly affecting the basal ganglia. These conditions present with multisystem clinical manifestations, most notably motor, cognitive, and behavioral disorders. To date, ten variants of NBIA have been identified, with BPAN, PKAN, and PLAN being the most common. This report presents five confirmed cases of type 4 NBIA, termed mitochondrial membrane protein-associated neurodegeneration (MPAN), detailing clinical and neuroimaging findings and its molecular genetic characteristics; MPAN is associated with mutations in the C19orf12 gene encoding a mitochondrial membrane protein.